비교리스트

 카트 문의
시장보고서
상품코드
1491450

세계의 간질성 방광염 치료제 시장(2024-2028년)

Global interstitial cystitis drugs market 2024-2028
발행일: | 리서치사: TechNavio | 페이지 정보: 영문 170 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

간질성 방광염 치료제 시장은 2023-2028년간 3억 8,540만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 5.85%를 나타낼 것으로 예측됩니다.

간질성 방광염 치료제 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 간질성 방광염의 높은 유병률, 간질성 방광염에 대한 인식 증가, 간질성 방광염 연구에 대한 보조금 증가 등이 시장 성장을 촉진하고 있습니다.

시장 범위
기준년 2024년
종료년 2028년
예측 기간 2024-2028년
성장 모멘텀 가속
YOY 2024 5.43%
CAGR 5.85%
증분액 3억 8,540만 달러

본 조사에서는 유전자 치료의 등장을 향후 몇 년간 간질성 방광염 치료제 시장 성장을 가속하는 주요인 중 하나로 꼽고 있습니다. 또한 환자 지원 프로그램이나 표적 치료에 대한 수요 증가는 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 구도

  • 시장 생태계
  • 시장 특징
  • 밸류체인 분석

제3장 시장 규모 평가

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모(2023년)
  • 시장 전망2023-2028년)

제4장 시장 규모 실적

  • 세계의 간질성 방광염 치료제 시장(2018-2022년)
  • 유형별 부문 분석(2018-2022년)
  • 유통 채널별 부문 분석(2018-2022년)
  • 지역별 부문 분석(2018-2022년)
  • 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁 위협
  • 시장 현황

제6장 시장 세분화 : 유형별

  • 시장 세분화
  • 비교 : 유형별
  • 경구 요법 : 시장 규모와 예측(2023-2028년)
  • 방광내 요법 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 유형별

제7장 시장 세분화 : 유통 채널별

  • 시장 세분화
  • 비교 : 유통 채널별
  • 병원 약국 : 시장 규모와 예측(2023-2028년)
  • 소매 약국 : 시장 규모와 예측(2023-2028년)
  • 온라인 약국 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 유통 채널별

제8장 고객 상황

  • 고객 상황 개요

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2023-2028년)
  • 유럽 : 시장 규모와 예측(2023-2028년)
  • 아시아 : 시장 규모와 예측(2023-2028년)
  • 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
  • 미국 : 시장 규모와 예측(2023-2028년)
  • 영국 : 시장 규모와 예측(2023-2028년)
  • 독일 : 시장 규모와 예측(2023-2028년)
  • 일본 : 시장 규모와 예측(2023-2028년)
  • 중국 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제, 기회, 성장 억제요인

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 기회 및 성장 억제요인

제11장 경쟁 구도

  • 개요
  • 경쟁 구도
  • 혼란 상황
  • 업계 리스크

제12장 경쟁 분석

  • 기업 개요
  • 기업의 시장 포지셔닝
  • Allergan
  • Amneal Pharmaceuticals Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Eli Lilly and Co.
  • Johnson and Johnson Services Inc.
  • Kyorin Pharmaceutical Co. Ltd.
  • PerrigPlco Co.
  • Pfizer Inc.
  • SEIKAGAKU CORP.
  • Sun Pharmaceutical Industries Ltd.
  • Taro Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.

제13장 부록

LSH 24.06.17

The interstitial cystitis drugs market is forecasted to grow by USD 385.4 mn during 2023-2028, accelerating at a CAGR of 5.85% during the forecast period. The report on the interstitial cystitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of interstitial cystitis, increasing awareness of interstitial cystitis, and increasing grants for research on interstitial cystitis.

Technavio's interstitial cystitis drugs market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.43%
CAGR5.85%
Incremental Value$385.4mn

By Type

  • Oral therapy
  • Intravesical therapy

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advent of gene therapy as one of the prime reasons driving the interstitial cystitis drugs market growth during the next few years. Also, patient-assistance programs and rising demand for targeted therapies will lead to sizable demand in the market.

The report on the interstitial cystitis drugs market covers the following areas:

  • Interstitial cystitis drugs market sizing
  • Interstitial cystitis drugs market forecast
  • Interstitial cystitis drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading interstitial cystitis drugs market vendors that include Allergan, Amneal Pharmaceuticals Inc., Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, Eli Lilly and Co., Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Kyorin Pharmaceutical Co. Ltd., Mission Pharmacal Co., PerrigPlco Co., Pfizer Inc., Purdue Pharma LP, SEIKAGAKU CORP., Sun Pharmaceutical Industries Ltd., Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd.. Also, the interstitial cystitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Distribution Channel
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Interstitial Cystitis Drugs Market 2018 - 2022
    • Historic Market Size - Data Table on Global Interstitial Cystitis Drugs Market 2018 - 2022 ($ million)
  • 4.2 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.3 Distribution Channel segment analysis 2018 - 2022
    • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

  • 6.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 6.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 6.3 Oral therapy - Market size and forecast 2023-2028
    • Chart on Oral therapy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Oral therapy - Market size and forecast 2023-2028 ($ million)
    • Chart on Oral therapy - Year-over-year growth 2023-2028 (%)
    • Data Table on Oral therapy - Year-over-year growth 2023-2028 (%)
  • 6.4 Intravesical therapy - Market size and forecast 2023-2028
    • Chart on Intravesical therapy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Intravesical therapy - Market size and forecast 2023-2028 ($ million)
    • Chart on Intravesical therapy - Year-over-year growth 2023-2028 (%)
    • Data Table on Intravesical therapy - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

  • 7.1 Market segments
    • Chart on Distribution Channel - Market share 2023-2028 (%)
    • Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 7.2 Comparison by Distribution Channel
    • Chart on Comparison by Distribution Channel
    • Data Table on Comparison by Distribution Channel
  • 7.3 Hospital pharmacies - Market size and forecast 2023-2028
    • Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
    • Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
  • 7.4 Retail pharmacies - Market size and forecast 2023-2028
    • Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
    • Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
    • Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
    • Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
  • 7.5 Online pharmacies - Market size and forecast 2023-2028
    • Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
    • Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
    • Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
    • Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by Distribution Channel
    • Market opportunity by Distribution Channel ($ million)
    • Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.9 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.10 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.11 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Allergan
    • Allergan - Overview
    • Allergan - Product / Service
    • Allergan - Key offerings
  • 12.4 Amneal Pharmaceuticals Inc.
    • Amneal Pharmaceuticals Inc. - Overview
    • Amneal Pharmaceuticals Inc. - Business segments
    • Amneal Pharmaceuticals Inc. - Key news
    • Amneal Pharmaceuticals Inc. - Key offerings
    • Amneal Pharmaceuticals Inc. - Segment focus
  • 12.5 Astellas Pharma Inc.
    • Astellas Pharma Inc. - Overview
    • Astellas Pharma Inc. - Product / Service
    • Astellas Pharma Inc. - Key news
    • Astellas Pharma Inc. - Key offerings
  • 12.6 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
  • 12.7 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key news
    • Eli Lilly and Co. - Key offerings
  • 12.8 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
  • 12.9 Kyorin Pharmaceutical Co. Ltd.
    • Kyorin Pharmaceutical Co. Ltd. - Overview
    • Kyorin Pharmaceutical Co. Ltd. - Product / Service
    • Kyorin Pharmaceutical Co. Ltd. - Key news
    • Kyorin Pharmaceutical Co. Ltd. - Key offerings
  • 12.10 PerrigPlco Co.
    • PerrigPlco Co. - Overview
    • PerrigPlco Co. - Business segments
    • PerrigPlco Co. - Key offerings
    • PerrigPlco Co. - Segment focus
  • 12.11 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
  • 12.12 SEIKAGAKU CORP.
    • SEIKAGAKU CORP. - Overview
    • SEIKAGAKU CORP. - Business segments
    • SEIKAGAKU CORP. - Key offerings
    • SEIKAGAKU CORP. - Segment focus
  • 12.13 Sun Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd. - Overview
    • Sun Pharmaceutical Industries Ltd. - Product / Service
    • Sun Pharmaceutical Industries Ltd. - Key news
    • Sun Pharmaceutical Industries Ltd. - Key offerings
  • 12.14 Taro Pharmaceutical Industries Ltd.
    • Taro Pharmaceutical Industries Ltd. - Overview
    • Taro Pharmaceutical Industries Ltd. - Product / Service
    • Taro Pharmaceutical Industries Ltd. - Key offerings
  • 12.15 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus
  • 12.16 Viatris Inc.
    • Viatris Inc. - Overview
    • Viatris Inc. - Business segments
    • Viatris Inc. - Key news
    • Viatris Inc. - Key offerings
    • Viatris Inc. - Segment focus
  • 12.17 Zydus Lifesciences Ltd.
    • Zydus Lifesciences Ltd. - Overview
    • Zydus Lifesciences Ltd. - Business segments
    • Zydus Lifesciences Ltd. - Key news
    • Zydus Lifesciences Ltd. - Key offerings
    • Zydus Lifesciences Ltd. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 market analysis
    • market analysis
  • 13.10 List of abbreviations
    • List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제